Eris Lifesciences Statistics

Total Valuation

Eris Lifesciences has a market cap or net worth of INR 182.69 billion. The enterprise value is 211.67 billion.

Market Cap	182.69B
Enterprise Value	211.67B

Important Dates

The next estimated earnings date is Tuesday, January 21, 2025.

Earnings Date	Jan 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Eris Lifesciences has 136.11 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	136.11M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	61.98%
Owned by Institutions (%)	24.17%
Float	40.79M

Valuation Ratios

The trailing PE ratio is 52.47 and the forward PE ratio is 38.97. Eris Lifesciences's PEG ratio is 2.73.

PE Ratio	52.47
Forward PE	38.97
PS Ratio	7.35
PB Ratio	6.59
P/TBV Ratio	n/a
P/FCF Ratio	30.80
P/OCF Ratio	n/a
PEG Ratio	2.73

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.27, with an EV/FCF ratio of 35.69.

EV / Earnings	60.74
EV / Sales	8.52
EV / EBITDA	25.27
EV / EBIT	36.21
EV / FCF	35.69

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.86.

Current Ratio	1.07
Quick Ratio	0.59
Debt / Equity	0.86
Debt / EBITDA	3.26
Debt / FCF	4.61
Interest Coverage	3.42

Financial Efficiency

Return on equity (ROE) is 13.09% and return on invested capital (ROIC) is 7.97%.

Return on Equity (ROE)	13.09%
Return on Assets (ROA)	6.71%
Return on Capital (ROIC)	7.97%
Revenue Per Employee	6.87M
Profits Per Employee	962,605
Employee Count	3,620
Asset Turnover	0.46
Inventory Turnover	2.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.55% in the last 52 weeks. The beta is 0.31, so Eris Lifesciences's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+51.55%
50-Day Moving Average	1,379.00
200-Day Moving Average	1,141.57
Relative Strength Index (RSI)	37.33
Average Volume (20 Days)	158,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eris Lifesciences had revenue of INR 24.85 billion and earned 3.48 billion in profits. Earnings per share was 25.58.

Revenue	24.85B
Gross Profit	18.95B
Operating Income	5.85B
Pretax Income	4.37B
Net Income	3.48B
EBITDA	8.26B
EBIT	5.85B
Earnings Per Share (EPS)	25.58

Full Income Statement

Balance Sheet

The company has 2.43 billion in cash and 27.35 billion in debt, giving a net cash position of -24.92 billion or -183.11 per share.

Cash & Cash Equivalents	2.43B
Total Debt	27.35B
Net Cash	-24.92B
Net Cash Per Share	-183.11
Equity (Book Value)	31.77B
Book Value Per Share	203.65
Working Capital	833.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.07 billion and capital expenditures -1.14 billion, giving a free cash flow of 5.93 billion.

Operating Cash Flow	7.07B
Capital Expenditures	-1.14B
Free Cash Flow	5.93B
FCF Per Share	43.58

Full Cash Flow Statement

Margins

Gross margin is 76.25%, with operating and profit margins of 23.52% and 14.02%.

Gross Margin	76.25%
Operating Margin	23.52%
Pretax Margin	17.58%
Profit Margin	14.02%
EBITDA Margin	33.24%
EBIT Margin	23.52%
FCF Margin	23.87%

Dividends & Yields

Eris Lifesciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	1.91%
FCF Yield	3.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a